Search results

3292 results

Sorted by Relevance . Sort by Date

  1. Non-Hodgkin's lymphoma

    Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

  2. Spondyloarthritis

    Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart

  3. Respiratory conditions

    Everything NICE has said on respiratory conditions in an interactive flowchart

  4. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  5. Osteoporosis

    Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

  6. Structural heart defects

    Everything NICE has said on structural heart defects in an interactive flowchart

  7. Autism spectrum disorder

    Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

  8. Smoking

    Everything NICE has said on preventing the uptake of smoking and helping people to stop smoking in an interactive flowchart

  9. Twin and triplet pregnancy

    Everything NICE has said on managing twin and triplet pregnancies in the antenatal and intrapartum period in an interactive flowchart

  10. Barrett's oesophagus

    Everything NICE has said on treating adults with Barrett's oesophagus who have high-grade dysplasia or early intramucosal cancer in an interactive flowchart

  11. Gallstone disease

    Everything NICE has said on diagnosing and managing gallstone disease in adults in an interactive flowchart

  12. Ectopic pregnancy and miscarriage

    Everything NICE has said on diagnosing and managing tubal ectopic pregnancy and miscarriage in early pregnancy in an interactive flowchart.

  13. Donor breast milk banks

    Everything NICE has said on the operation of donor breast milk bank services in an interactive flowchart

  14. Colonoscopic surveillance

    Everything NICE has said on colonoscopic surveillance for people with inflammatory bowel disease or adenomas in an interactive flowchart.

  15. Sedation in children and young people

    Everything NICE has said on sedation for diagnostic and therapeutic procedures in infants, children and young people in an interactive flowchart

  16. Liver cancers

    Everything NICE has said on liver and bile duct cancers in an interactive flowchart

  17. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  18. Non-alcoholic fatty liver disease

    Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart

  19. Cirrhosis

    Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart

  20. Multiple sclerosis

    Everything NICE has said on multiple sclerosis in an interactive flowchart

  21. Neonatal jaundice

    Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart

  22. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  23. Safer insulin prescribing (KTT20)

    This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  24. Multimorbidity and polypharmacy (KTT18)

    This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  25. Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  26. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  27. Wound care products (KTT14)

    This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  28. Non-steroidal anti-inflammatory drugs (KTT13)

    The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  29. Antimicrobial stewardship: prescribing antibiotics (KTT9)

    This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  30. Antipsychotics in people living with dementia (KTT7)

    This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  31. Hypnotics (KTT6)

    This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  32. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  33. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  34. Shared decision making (KTT23)

    This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

  35. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  36. Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

    This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .